GB2010675B - Treating hypertension and medicaments therefor - Google Patents

Treating hypertension and medicaments therefor

Info

Publication number
GB2010675B
GB2010675B GB7849703A GB7849703A GB2010675B GB 2010675 B GB2010675 B GB 2010675B GB 7849703 A GB7849703 A GB 7849703A GB 7849703 A GB7849703 A GB 7849703A GB 2010675 B GB2010675 B GB 2010675B
Authority
GB
United Kingdom
Prior art keywords
treating hypertension
medicaments therefor
medicaments
therefor
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7849703A
Other languages
English (en)
Other versions
GB2010675A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB2010675(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of GB2010675A publication Critical patent/GB2010675A/en
Application granted granted Critical
Publication of GB2010675B publication Critical patent/GB2010675B/en
Priority to MYPI87003001A priority Critical patent/MY102991A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB7849703A 1977-12-27 1978-12-21 Treating hypertension and medicaments therefor Expired GB2010675B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI87003001A MY102991A (en) 1977-12-27 1987-10-31 Medicaments for treating hypertension.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27

Publications (2)

Publication Number Publication Date
GB2010675A GB2010675A (en) 1979-07-04
GB2010675B true GB2010675B (en) 1982-06-16

Family

ID=25343256

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7849703A Expired GB2010675B (en) 1977-12-27 1978-12-21 Treating hypertension and medicaments therefor

Country Status (30)

Country Link
JP (1) JPS54110333A (sv)
AR (1) AR230378A1 (sv)
AU (1) AU526239B2 (sv)
BE (1) BE873092A (sv)
CA (1) CA1120400A (sv)
CH (1) CH642542A5 (sv)
DE (1) DE2854316C3 (sv)
DK (1) DK578778A (sv)
EG (1) EG14178A (sv)
FI (1) FI783991A (sv)
FR (1) FR2413089A1 (sv)
GB (1) GB2010675B (sv)
GR (1) GR72951B (sv)
HK (1) HK45483A (sv)
HU (1) HU178747B (sv)
IE (1) IE48306B1 (sv)
IL (1) IL56281A (sv)
IT (1) IT1202811B (sv)
KE (1) KE3235A (sv)
LU (1) LU80709A1 (sv)
MY (2) MY8300240A (sv)
NL (2) NL192870C (sv)
NO (1) NO784357L (sv)
NZ (1) NZ189159A (sv)
PH (1) PH22111A (sv)
PL (1) PL212188A1 (sv)
PT (1) PT68983A (sv)
SE (1) SE445173B (sv)
SG (1) SG41482G (sv)
ZA (1) ZA786948B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (ja) * 1978-10-05 1983-06-25 ウェルファイド株式会社 環状イミノカルボン酸誘導体およびその塩類
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
PH22111A (en) 1988-06-01
AR230378A1 (es) 1984-04-30
CA1120400A (en) 1982-03-23
NZ189159A (en) 1984-12-14
GB2010675A (en) 1979-07-04
NL980017I1 (nl) 1998-07-01
IE782413L (en) 1979-06-27
AU4204178A (en) 1979-07-05
IT7831266A0 (it) 1978-12-22
NL7812164A (nl) 1979-06-29
IE48306B1 (en) 1984-12-12
PT68983A (en) 1979-01-01
IL56281A (en) 1983-05-15
KE3235A (en) 1982-11-05
NL192870C (nl) 1998-04-02
AU526239B2 (en) 1982-12-23
MY8300240A (en) 1983-12-31
DE2854316A1 (de) 1979-07-05
GR72951B (sv) 1984-01-17
NL192870B (nl) 1997-12-01
CH642542A5 (de) 1984-04-30
ZA786948B (en) 1980-04-30
HU178747B (en) 1982-06-28
FI783991A (fi) 1979-06-28
DK578778A (da) 1979-06-28
JPS54110333A (en) 1979-08-29
SE7813277L (sv) 1979-06-28
EG14178A (en) 1984-06-30
DE2854316C3 (de) 1994-12-22
BE873092A (fr) 1979-06-27
IL56281A0 (en) 1979-03-12
SE445173B (sv) 1986-06-09
NO784357L (no) 1979-06-28
HK45483A (en) 1983-10-28
SG41482G (en) 1985-01-11
LU80709A1 (de) 1979-04-13
FR2413089B1 (sv) 1980-12-26
PL212188A1 (sv) 1980-02-11
IT1202811B (it) 1989-02-09
MY102991A (en) 1993-03-31
FR2413089A1 (fr) 1979-07-27
DE2854316C2 (sv) 1989-08-10
JPS647045B2 (sv) 1989-02-07

Similar Documents

Publication Publication Date Title
GB2036001B (en) Cyanocarboxamidines and quinazoline process
GR63284B (en) Photoactivated bleach-compositions and processes
NZ192231A (en) 2-chloro-5-trichloromethyl-pyridine and 2,3-dichloro-5-trichloromethylpyridine
ZA783464B (en) Dihydropyridazones,their manufacture,and therapeutic agents containing dihydropyridazones
JPS5488920A (en) Piled aheer glass and treatment thereof
JPS53141292A (en) Novel imidazoazine and * imidazodiazine
JPS53146976A (en) Waterrsoluble ampholite and manufacture thereof
GB2007216B (en) Isochromans siothiochromans 2-benzoxepins and benzothieps
GB2010675B (en) Treating hypertension and medicaments therefor
JPS53125604A (en) Pump and pump part
JPS5441851A (en) Arylphosphonite and thiophosphonite
JPS53111095A (en) Pyroloquinoxalines and pyrolobenzodiazepinons
JPS5452067A (en) Arylphosphonite and thiophosphonite
ZA781598B (en) 4-alkylthio-2-trifluoromethylalkanesulfonanilides and derivatives thereof
JPS5452084A (en) 11aryll55carboxyy22pyridones and use thereof
PH14777A (en) Heterocyclopyrimidine and therapeutic process thereof
JPS5481237A (en) Alphaaalkyldihydrocinnamaldehydes and manufacture
JPS5410066A (en) Antiismoking material and treating
JPS5416489A (en) Antidyeing treatment
GB2002231B (en) Hypertension treating agent
IL54850A0 (en) Bufadienolide and bufatrienolide-ethers
GB2009740B (en) 3-ureidochromone and 3-ureidothiochromone compounds
JPS5448762A (en) 44hydroxyy4*66diaryll4hhimidazoles and manufacture
JPS53112882A (en) Benzoylpiperidylalkylindoles and and related compounds
JPS5434514A (en) Vibrationnsuppressing and sounddinsulating structure

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 19981220